SCHEMBL5793708

SCHEMBL5793708

COC(=O)c1ccc2[nH]c(CN3CCCC3)cc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.57
ALDH1A1 P00352 4/20 0.57
HSD17B10 Q99714 2/20 0.57
HPGD P15428 1/20 0.57
ALOX15 P16050 1/20 0.57
CASP1 P29466 1/20 0.57
PDGFRB P09619 1/20 0.51
KDR P35968 1/20 0.51
MLLT1 Q03111 1/20 0.49
HRH3 Q9Y5N1 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.47
ALOX12 P18054 1/20 0.47
MAPK1 P28482 1/20 0.47
CHEK1 O14757 2/20 0.46
CDK7 P50613 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
TSHR P16473 1/20 0.46
HRH4 Q9H3N8 1/20 0.44
NPSR1 Q6W5P4 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25202850 0.84 PDGFRB (0.47) KDM4EALDH1A1HSD17B10HPGDALOX15
SCHEMBL22391564 0.81 CHRM3 (0.47) KDM4EALDH1A1HSD17B10HPGDALOX15
SCHEMBL5794918 0.80 MEN1 (0.49) KDM4EALDH1A1HSD17B10HPGDKDR
SCHEMBL5882117 0.80 MEN1 (0.49) KDM4EALDH1A1HSD17B10HPGDHRH3
SCHEMBL5881784 0.79 NPC1 (0.47) KDM4EALDH1A1HSD17B10HPGDKDR
SCHEMBL5795808 0.78 CHEK1 (0.45) KDM4EALDH1A1HSD17B10HPGDHRH3
SCHEMBL5882041 0.78 MEN1 (0.56) KDM4EALDH1A1HSD17B10HPGDKDR
SCHEMBL7411185 0.75 L3MBTL1 (0.51) KDM4EALDH1A1HSD17B10HPGDKDR
SCHEMBL554335 0.75 ALDH1A1 (0.66) KDM4EALDH1A1HSD17B10HPGDHRH3
SCHEMBL22391731 0.74 CCNK (0.45) KDM4EALDH1A1HSD17B10HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006035308-A1 HISTAMINE-3 RECEPTOR ANTAGONISTS PFIZER PRODUCTS INC. (US) 2006-04-06 WO claimed
US-20060069087-A1 Histamine-3 receptor antagonists PFIZER INC 2006-03-30 US claimed
WO-2006035308-A1 HISTAMINE-3 RECEPTOR ANTAGONISTS PFIZER PRODUCTS INC. (US) 2006-04-06 WO disclosed
US-20060069087-A1 Histamine-3 receptor antagonists PFIZER INC 2006-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060069087-A1 Histamine-3 receptor antagonists HRH3, HRH4, HRH2 KDM4E 3231/4885ALDH1A1 1129/4885HSD17B10 1970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.